Skip to main content

Table 2 Subject demographics

From: A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin

 

UP446250 mg/day

UP446500 mg/day

Celecoxib200 mg/day

Placebo

Total (N)

15

15

15

15

Mean (SD) Age

62.8 (10.8)

54.6 (14.8)

57.6 (12.6)

55.3 (14.3)

Male N (%)

5 (33)

6 (40)

5 (33)

6 (40)

Female N (%)

10 (67)

9 (60)

10 (67)

9 (60)